Home
About
FAQ
History (24)
Molecular targeted a-particle therapy for oncologic applications.
Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop.
Phenylalanine-tRNA Ligase
Gallbladder Emptying
Urinary F2-isoprostanes and the risk of hypertension.
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Urinary F2-isoprostanes and the risk of hypertension.
Melton CD, Luo R, Wong BJ, Spasojevic I, Wagenknecht LE, D'Agostino RB, Il'yasova D. Urinary F2-isoprostanes and the risk of hypertension. Ann Epidemiol. 2017 06; 27(6):391-396.
View in:
PubMed
subject areas
Adult
African Americans
Blood Pressure
Cross-Sectional Studies
Diabetes Mellitus, Type 2
European Continental Ancestry Group
F2-Isoprostanes
Female
Hispanic Americans
Humans
Hypertension
Incidence
Insulin Resistance
Lipid Peroxidation
Male
Middle Aged
Oxidative Stress
Prospective Studies
Risk Factors
United States
authors with profiles
Lynne E. Wagenknecht DrPH
Ralph B. D'Agostino PhD, FASA